Literature DB >> 21753256

Sex differences in cardiomyocyte connexin43 expression.

Brian L Stauffer1, Rebecca D Sobus, Carmen C Sucharov.   

Abstract

Decreases in cardiac connexin43 (Cx43) play a critical role in abnormal cell-to-cell communication and have been linked to the resistance of the female heart to arrhythmias. We therefore hypothesized that Cx43 expression would be greater in female cardiomyocytes than in male cardiomyocytes under pathologic conditions. Adult ventricular myocytes were isolated from male and female rats and treated with phenylephrine (PE), a well-established pathologic stimulus. Cx43 gene and protein expression was determined. The expression of micro-RNA-1 (miR-1), a micro-RNA known to control Cx43 protein expression in cardiomyocytes, was also determined. Cx43 mRNA and protein levels were significantly higher in the female cardiomyocytes than in the male cardiomyocytes (mRNA: 1.4-fold; Protein: 5-fold, both P < 0.05) under both basal and pathologic conditions. PE treatment increased Cx43 expression only in female cardiomyocytes. Cx43 phosphorylation, a marker of preserved Cx43 function, was also higher (P < 0.05), and The expression of miR-1 was lower (P < 0.05) in the female cardiomyocytes after PE treatment. The expression of miR-1 was unchanged by PE treatment in male cardiomyocytes. Thus, a sex difference in miR-1 may be responsible for the sex difference in Cx43 expression in cardiomyocytes under pathologic conditions. Taken together, our results demonstrate a sex difference in Cx43 expression and site-specific phosphorylation that favors cardioprotection in female cardiomyocytes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21753256      PMCID: PMC3136750          DOI: 10.1097/FJC.0b013e31821b70b4

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  57 in total

1.  Transcriptional regulation of beta2-microglobulin demonstrated via a novel genomic and proteomic analysis of percutaneously collected peripheral atheroma.

Authors:  Brian L Stauffer; Erich J Kushner; Ted Wulfman; Thomas Zeller; Rebecca Sobus; Christian M Westby
Journal:  Clin Transl Sci       Date:  2008-12       Impact factor: 4.689

2.  Heart disease and stroke statistics--2010 update: a report from the American Heart Association.

Authors:  Donald Lloyd-Jones; Robert J Adams; Todd M Brown; Mercedes Carnethon; Shifan Dai; Giovanni De Simone; T Bruce Ferguson; Earl Ford; Karen Furie; Cathleen Gillespie; Alan Go; Kurt Greenlund; Nancy Haase; Susan Hailpern; P Michael Ho; Virginia Howard; Brett Kissela; Steven Kittner; Daniel Lackland; Lynda Lisabeth; Ariane Marelli; Mary M McDermott; James Meigs; Dariush Mozaffarian; Michael Mussolino; Graham Nichol; Véronique L Roger; Wayne Rosamond; Ralph Sacco; Paul Sorlie; Véronique L Roger; Randall Stafford; Thomas Thom; Sylvia Wasserthiel-Smoller; Nathan D Wong; Judith Wylie-Rosett
Journal:  Circulation       Date:  2009-12-17       Impact factor: 29.690

3.  AFos dissociates cardiac myocyte hypertrophy and expression of the pathological gene program.

Authors:  Mark Y Jeong; Koichiro Kinugawa; Charles Vinson; Carlin S Long
Journal:  Circulation       Date:  2005-03-28       Impact factor: 29.690

4.  Chamber-related differences in connexin expression in the human heart.

Authors:  C Vozzi; E Dupont; S R Coppen; H I Yeh; N J Severs
Journal:  J Mol Cell Cardiol       Date:  1999-05       Impact factor: 5.000

5.  Early response kinase and PI 3-kinase activation in adult cardiomyocytes and their role in hypertrophy.

Authors:  K D Schlüter; A Simm; M Schäfer; G Taimor; H M Piper
Journal:  Am J Physiol       Date:  1999-05

6.  Phenylephrine induces activation of CREB in adult rat cardiac myocytes through MSK1 and PKA signaling pathways.

Authors:  Thomais Markou; Margarita Hadzopoulou-Cladaras; Antigone Lazou
Journal:  J Mol Cell Cardiol       Date:  2004-11       Impact factor: 5.000

7.  Arrhythmogenic cardiomyopathy and abnormalities of cell-to-cell coupling.

Authors:  Jeffrey E Saffitz
Journal:  Heart Rhythm       Date:  2009-03-03       Impact factor: 6.343

Review 8.  Connexin43 phosphorylation: structural changes and biological effects.

Authors:  Joell L Solan; Paul D Lampe
Journal:  Biochem J       Date:  2009-04-15       Impact factor: 3.857

Review 9.  Regulation of myocardial connexins during hypertrophic remodelling.

Authors:  Birgit E J Teunissen; Habo J Jongsma; Marti F A Bierhuizen
Journal:  Eur Heart J       Date:  2004-11       Impact factor: 29.983

10.  Limited forward trafficking of connexin 43 reduces cell-cell coupling in stressed human and mouse myocardium.

Authors:  James W Smyth; Ting-Ting Hong; Danchen Gao; Jacob M Vogan; Brian C Jensen; Tina S Fong; Paul C Simpson; Didier Y R Stainier; Neil C Chi; Robin M Shaw
Journal:  J Clin Invest       Date:  2009-12-28       Impact factor: 14.808

View more
  23 in total

1.  Transgenic over-expression of YY1 induces pathologic cardiac hypertrophy in a sex-specific manner.

Authors:  Brian L Stauffer; Karen Dockstader; Gloria Russell; Jamie Hijmans; Lisa Walker; Mackenzie Cecil; Kimberly Demos-Davies; Allen Medway; Timothy A McKinsey; Carmen C Sucharov
Journal:  Biochem Biophys Res Commun       Date:  2015-04-29       Impact factor: 3.575

2.  Sex differences in response to miRNA-34a therapy in mouse models of cardiac disease: identification of sex-, disease- and treatment-regulated miRNAs.

Authors:  Bianca C Bernardo; Jenny Y Y Ooi; Aya Matsumoto; Yow Keat Tham; Saloni Singla; Helen Kiriazis; Natalie L Patterson; Junichi Sadoshima; Susanna Obad; Ruby C Y Lin; Julie R McMullen
Journal:  J Physiol       Date:  2016-07-20       Impact factor: 5.182

3.  Cardiac myocyte alternans in intact heart: Influence of cell-cell coupling and β-adrenergic stimulation.

Authors:  Karin P Hammer; Senka Ljubojevic; Crystal M Ripplinger; Burkert M Pieske; Donald M Bers
Journal:  J Mol Cell Cardiol       Date:  2015-03-28       Impact factor: 5.000

4.  Hyperandrogenemia reduces endothelium-derived hyperpolarizing factor-mediated relaxation in mesenteric artery of female rats.

Authors:  Jay S Mishra; Amar S More; Gary D V Hankins; Sathish Kumar
Journal:  Biol Reprod       Date:  2017-06-01       Impact factor: 4.285

Review 5.  Connexin 43 is an emerging therapeutic target in ischemia/reperfusion injury, cardioprotection and neuroprotection.

Authors:  Rainer Schulz; Philipp Maximilian Görge; Anikó Görbe; Péter Ferdinandy; Paul D Lampe; Luc Leybaert
Journal:  Pharmacol Ther       Date:  2015-06-11       Impact factor: 12.310

6.  Estrogen-Dependent Disruption of Adiponectin-Connexin43 Signaling Underlies Exacerbated Myocardial Dysfunction in Diabetic Female Rats.

Authors:  Korin E Leffler; Abdel A Abdel-Rahman
Journal:  J Pharmacol Exp Ther       Date:  2018-12-06       Impact factor: 4.030

7.  Amylin and diabetic cardiomyopathy - amylin-induced sarcolemmal Ca2+ leak is independent of diabetic remodeling of myocardium.

Authors:  Miao Liu; Amanda Hoskins; Nirmal Verma; Donald M Bers; Sanda Despa; Florin Despa
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-10-21       Impact factor: 5.187

Review 8.  Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications.

Authors:  Luc Leybaert; Paul D Lampe; Stefan Dhein; Brenda R Kwak; Peter Ferdinandy; Eric C Beyer; Dale W Laird; Christian C Naus; Colin R Green; Rainer Schulz
Journal:  Pharmacol Rev       Date:  2017-10       Impact factor: 25.468

Review 9.  An emerging role for microRNAs in sexually dimorphic neurobiological systems.

Authors:  Toni R Pak; Yathindar S Rao; Sarah A Prins; Natasha N Mott
Journal:  Pflugers Arch       Date:  2013-02-09       Impact factor: 3.657

Review 10.  Lymphatic Function and Dysfunction in the Context of Sex Differences.

Authors:  Claire E Trincot; Kathleen M Caron
Journal:  ACS Pharmacol Transl Sci       Date:  2019-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.